Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease

Rong-Hong Ma1, Yao Zhang2, Xiao-Yue Hong3

  • 1Department of Laboratory Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Insights

Abnormal tau protein hyperphosphorylation, driven by kinases like GSK-3β and phosphatases like PP2A, causes neurofibrillary tangles in Alzheimer's disease (AD), leading to cognitive decline.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Tau is a microtubule-associated protein crucial for neuronal structure.
  • Hyperphosphorylated tau aggregates into neurofibrillary tangles in Alzheimer's disease (AD) and tauopathies.
  • Dysregulation of protein kinases and phosphatases, particularly GSK-3β and PP2A, causes tau hyperphosphorylation.

Purpose of the Study:

  • To review upstream regulators of glycogen synthase kinase-3β (GSK-3β) and protein phosphatase 2A (PP2A) activity.
  • To discuss mechanisms of tau-induced synaptic toxicity.
  • To highlight recent findings on tau phosphorylation pathways.

Main Methods:

  • Literature review focusing on upstream factors regulating GSK-3β and PP2A.
  • Analysis of pathways involved in tau hyperphosphorylation.
  • Discussion of mechanisms linking hyperphosphorylated tau to synaptic dysfunction.

Main Results:

  • Identified key upstream regulators influencing GSK-3β and PP2A activities.
  • Detailed pathways contributing to tau hyperphosphorylation.
  • Elucidated potential mechanisms of tau-mediated synaptic toxicity.

Conclusions:

  • Imbalanced regulation of GSK-3β and PP2A is central to tauopathies like AD.
  • Understanding these regulatory pathways is critical for developing therapeutic strategies.
  • Further research into tau-induced synaptic toxicity may reveal new treatment targets.

Related Concept Videos

Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
54.9K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
6.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K